InMed Pharmaceuticals Inc

NASDAQ:INM   12:36:19 AM EDT
3.04
-0.21 (-6.46%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

InMed Pharmaceuticals Inc Stock, NASDAQ:INM

885 West Georgia Street, Suite 1445, Vancouver, British Columbia V6C 3E8
Canada
Phone: +1.604.669.7207
Number of Employees: 13

Description

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.